Literature DB >> 23621966

Economics of psychosocial factors in patients with cardiovascular disease.

Benjamin A Rodwin1, Tanya M Spruill, Joseph A Ladapo.   

Abstract

Growing evidence supports a causal relationship between cardiovascular disease and psychosocial factors such as mental health and behavioral disorders, acute and chronic stress, and low socioeconomic status. While this has enriched our understanding of the interaction between cardiovascular risk factors, much less is known about its economic implications. In this review, we evaluate the economic impact of psychosocial factors in persons at risk for or diagnosed with cardiovascular disease. Most studies have focused on depression and almost uniformly conclude that patients with cardiovascular disease and comorbid depression use a greater number of ambulatory and hospital services and incur higher overall costs. Additionally, comorbid depression may also reduce employment productivity in patients with cardiovascular disease, further magnifying its economic impact. Recent randomized trials have demonstrated that innovative care delivery models that target depression may reduce costs or at least be cost neutral while improving quality of life. The growing population burden and overlap of cardiovascular disease, comorbid mental illness, and other psychosocial factors suggest that future research identifying cost-effective or cost-saving treatment models may have significant health and economic implications.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23621966     DOI: 10.1016/j.pcad.2013.03.006

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  8 in total

1.  Towards Robot-Assisted Echocardiographic Monitoring in Catheterization Laboratories : Usability-Centered Manipulator for Transesophageal Echocardiography.

Authors:  Christina Pahl; Henning Ebelt; Mostafa Sayahkarajy; Eko Supriyanto; Amiliana Soesanto
Journal:  J Med Syst       Date:  2017-08-15       Impact factor: 4.460

Review 2.  Economic menace of diabetes in India: a systematic review.

Authors:  Sumit Oberoi; Pooja Kansra
Journal:  Int J Diabetes Dev Ctries       Date:  2020-06-17

3.  Elections have Consequences: Partisan Politics may be Literally Killing Us.

Authors:  Alexander Maas; Liang Lu
Journal:  Appl Health Econ Health Policy       Date:  2020-12-18       Impact factor: 2.561

4.  Efficacy and cost-effectiveness of a therapist-assisted web-based intervention for depression and anxiety in patients with ischemic heart disease attending cardiac rehabilitation [eMindYourHeart trial]: a randomised controlled trial protocol.

Authors:  Susanne S Pedersen; Christina M Andersen; Robert Ahm; Søren J Skovbakke; Robin Kok; Charlotte Helmark; Uffe K Wiil; Thomas Schmidt; Kim Rose Olsen; Jacob Hjelmborg; Ann-Dorthe Zwisler; Lisbeth Frostholm
Journal:  BMC Cardiovasc Disord       Date:  2021-01-07       Impact factor: 2.298

5.  Association between allergic rhinitis and metabolic conditions: a nationwide survey in Korea.

Authors:  In Cheol Hwang; Yong Joo Lee; Hong Yup Ahn; Sang Min Lee
Journal:  Allergy Asthma Clin Immunol       Date:  2016-01-22       Impact factor: 3.406

6.  Economic Impact of Subsequent Depression in Patients With a New Diagnosis of Stable Angina: A Population-Based Study.

Authors:  Natalie Szpakowski; Feng Qiu; Shannon Masih; Paul Kurdyak; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2017-10-11       Impact factor: 5.501

7.  Evaluation of the Impact of Virtual Reality-Enhanced Cardiac Rehabilitation on Depressive and Anxiety Symptoms in Patients with Coronary Artery Disease: A Randomised Controlled Trial.

Authors:  Sandra Jóźwik; Błażej Cieślik; Robert Gajda; Joanna Szczepańska-Gieracha
Journal:  J Clin Med       Date:  2021-05-16       Impact factor: 4.241

8.  Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.

Authors:  Sae Takada; Allison J Ober; Judith S Currier; Noah J Goldstein; Tamara B Horwich; Brian S Mittman; Suzanne B Shu; Chi-Hong Tseng; Tara Vijayan; Soma Wali; William E Cunningham; Joseph A Ladapo
Journal:  Prog Cardiovasc Dis       Date:  2020-02-19       Impact factor: 8.194

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.